Displaying drugs 1101 - 1125 of 2779 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Foscarnet | 126.0053 CH3O5P | An antiviral used to treat CMV, HIV, and HSV infections. | Phosphonic Acid Derivatives | |
Fosdenopterin | 363.223 C10H14N5O8P | An exogenous form of cyclic pyranopterin monophosphate (cPMP) used as a replacement substrate in patients with molybdenum cofactor deficiency (MoCD) type A. | Various Alimentary Tract and Metabolism Products | |
Fosfomycin | 138.059 C3H7O4P | A broad spectrum antibiotic used to treat uncomplicated urinary tract infections. | Anti-Bacterial Agents / Organophosphonates | |
Fosinopril | 563.672 C30H46NO7P | An ACE inhibitor used to treat mild to moderate hypertension, congestive heart failure, and to slow the progression of renal disease in hypertensive diabetics. | ACE Inhibitors and Diuretics | |
Foslevodopa | 277.169 C9H12NO7P | Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced... | Dopa and Dopa Derivatives | |
Fosnetupitant | 688.608 C31H35F6N4O5P | A medication used in combination with others to prevent chemotherapy associated nausea and vomiting. | Substance P/Neurokinin-1 Receptor Antagonist | |
Fosphenytoin | 362.2739 C16H15N2O6P | An antiepileptic agent used for the management of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. | Anti-epileptic Agent / Hydantoins / Prodrugs / Sodium Channel Blockers | |
Fospropofol | 288.2766 C13H21O5P | A sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures. | Anesthetics, General / Hypnotics and Sedatives | |
Fostamatinib | 580.4595 C23H26FN6O9P | A spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia after attempting one other treatment. | Amines / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Experimental Unapproved Treatments for COVID-19 / Hemostatics / Kinase Inhibitor / Oxazines / Phosphodiesterase 5 Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A9 Substrates / Vasodilating Agents | |
Fostemsavir | 583.498 C25H26N7O8P | An antiretroviral HIV-1 attachment inhibitor targeted against the gp120 subunit within the HIV-1 gp160 envelope glycoprotein. | Anti-HIV Agents / HIV Fusion Inhibitors | |
Framycetin | 614.6437 C23H46N6O13 | An aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus. | Medicated Dressings With Antiinfectives | |
Frovatriptan | 243.3043 C14H17N3O | A 5-HT1B/1D receptor agonist used to treat migraines. | Selective Serotonin 5-HT1 Receptor Agonists / Serotonin Receptor Agonists | |
Fructose | 180.1559 C6H12O6 | Not Available | Carbohydrates | |
Fruquintinib | 393.399 C21H19N3O5 | A VEGF receptor inhibitor used to treat metastatic colorectal cancer. | Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring | |
Fulvestrant | 606.78 C32H47F5O3S | An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. | Anti-Estrogens | |
Furosemide | 330.744 C12H11ClN2O5S | A loop diuretic used to treat hypertension and edema in congestive heart failure, liver cirrhosis, renal disease, and hypertension. | High-Ceiling Diuretics and Potassium-Sparing Agents / Sulfonamides | |
Fursultiamine | 398.543 C17H26N4O3S2 | Compound used for therapy of thiamine deficiency. It has also been suggested for several non-deficiency disorders but has not yet proven useful. Fursultiamine is a vitamin B1 derivative. | Vitamin B Complex | |
Fusafungine | 639.8204 C33H57N3O9 | Fusafungine is an antibiotic from Fusarium lateririum, and is used for the treatment of respiratory infections. | Anti-Bacterial Agents | |
Fusidic acid | 516.7092 C31H48O6 | A topical antibacterial agent used to prevent and treat mild to moderate skin infections caused by susceptible bacteria. | Medicated Dressings With Antiinfectives / Steroid Antibacterials | |
Futibatinib | 418.457 C22H22N6O3 | A kinase inhibitor used to treat intrahepatic cholangiocarcinoma in previously treated adults. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors | |
Gabapentin | 171.2368 C9H17NO2 | An anticonvulsant medication used in the management of peripheral neuropathic pains, postherpetic neuralgia, and partial-onset seizures. | Gabapentinoids | |
Gabapentin enacarbil | 329.393 C16H27NO6 | A gabapentin prodrug used to treat Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN). | Anti-epileptic Agent | |
Gadobenic acid | 667.73 C22H28GdN3O11 | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media | |
Gadobutrol | 604.72 C18H31GdN4O9 | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media | |
Gadodiamide | 573.66 C16H26GdN5O8 | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media |
Displaying drugs 1101 - 1125 of 2779 in total